Pam Simons

Med device clinreg exec; Dance Mom, Golf for the Gift, Wife to THE @rodsimons, Mother to Annie and Tar Heel Alum #dreambig #foreverfamilies

[AtriCure, Inc. @AtriCure]

The LeAAPS Trial evaluating LAAE to prevent ischemic stroke in high-risk cardiac surgery patients without a history of Afib. This groundbreaking research aims to elevate patient care standards by validating LAAE's effectiveness.

Learn more about LeAAPS: https://t.co/d2Zv37Syy0

[AtriCure, Inc. @AtriCure]

Can preemptive LAA exclusion shield cardiac patients from future strokes? LeAAPS™ aims to evaluate whether individuals with elevated stroke risk but no Afib benefit from LAAE using AtriClip® devices.

Learn more: https://t.co/P1GDV1O9oH
#StrokeAwarenessMonth #Stroke #LAAE

[AtriCure, Inc. @AtriCure]

The HEAL-IST Trial is evaluating a hybrid sinus node sparing procedure for symptomatic, drug refractory or intolerant IST. IST symptoms include high heart rate, palpitations, lightheadedness, fainting, and shortness of breath in young, otherwise healthy patients. Learn more: https://t.co/xx89JiSf3x

#WomensHealthWeek #ClinicalTrial #IST

[AtriCure, Inc. @AtriCure]

Congratulations to Dr. Steven Hunter and his team at @SheffieldHosp for the 1st first UK patient enrolled in the LeAAPS™ trial!​

LeAAPS is the largest randomized clinical trial in cardiac surgery history and will assess whether LAAE using AtriClip™ devices can reduce stroke risk in cardiac surgery patients without a history of Afib. ​

To learn more, visit https://t.co/uRt9WDti6E.​

#ClinicalTrial #CardioTwitter #Afib

[AtriCure, Inc. @AtriCure]

More than 2,000 participants are now enrolled in the LeAAPS™ Trial! As the largest randomized clinical trial in cardiac surgery history, the trial is set to evaluate whether LAAE can reduce stroke in cardiac surgery patients with no prior history of Afib.
Learn more: https://t.co/uRt9WDtPWc
#ClinicalStudy #Stroke

[Pam Simons @p2simons]

@AtriCureCEO Thank you, Mike! You were so inspiring to our team!!

[D2Football @D2Football]

TE @TheDG_88, @cjkiss17, @mrigerman35, and @tommywashingt12 are a few of the 100 players on the Elite 100 Watch List.

Team
https://t.co/V8PtvpjVc0

Season preview Sunday at 8pm EDT https://t.co/4SVLAfwRSP

[Mike Carrel @AtriCureCEO]

The 150th patient in the ICE-AFIB clinical trial was treated at the University of Michigan last week by Dr. Matthew Romano and Dr. Steven Bolling. Congrats to all, including lead PI @DrNivAd! #clinicaltrials #Afib
@UMichCTSurgery
@UMichSurgery

[Mike Carrel @AtriCureCEO]

Great to be with 870 other attendees at the AATS #Mitral2023, learning from surgeons presenting about #Afib trials and LeAAPS. Clinical science matters for patients!
 @AATSHQ

[AmericanHeartAssocMN @HeartAssocMN]

Thank you for all your support of Twin Cities Go Red for Women. We can’t wait to celebrate Go Red’s 20th birthday with you next year! ❤️ #GoRedMN

And a special thank you to these sponsors for their continued commitment in 2024:
@MHealthFairview
@AtriCure
@BeckmanDx
@Philips

[Pam Simons @p2simons]

Red is my power color… especially on #NationalWearRedDay for heart disease! Proud to represent @AtriCure, @HeartAssocMN and @GoRedForWomen as ELT member and MN Circle of Red Chair! #GoRedForWomen #RodisMyWhy ❤️

[AtriCure, Inc. @AtriCure]

The first patient in the LeAAPS™ trial has been treated! LeAAPS will evaluate the safety & effectiveness of the prophylactic use of AtriClip® devices for stroke reduction in cardiac surgery patients without a pre-op Afib diagnosis. Read more here: https://t.co/Gj2qrNEDOs

[Mike Carrel @AtriCureCEO]

Pleased to announce first patient in the LeAAPS trial! One of the largest cardiac trials ever, and it will evaluate effectiveness and safety of using the AtriClip to prevent stroke in patients undergoing cardiac surgery with an elevated risk of stroke. https://t.co/esLRv5dmDZ

[Mike Carrel @AtriCureCEO]

✈️ to #SanFran to connect with and learn from global leaders, healthcare innovators and investors during the @jpmorgan Healthcare Conference. Honored to share the many ways @AtriCure impacts #patients globally who suffer with advanced forms of #Afib and post-op pain! #DamarStrong

[Mike Carrel @AtriCureCEO]

Collaboration. That word was used many times this week as @AtriCure leaders gathered in person to align and launch 2023. We will make a difference for more than 100,000 patients this year, and that will take all of us working together on one mission. Can’t wait to get started!

[AtriCure, Inc. @AtriCure]

Celebrating our partnership with the @AmericanHeart for the 28th annual Twin Cities Heart Ball. A special thanks to @Elmouelhi for his leadership in building healthier lives and communities as part of the event’s Executive Leadership Team!

[Mike Carrel @AtriCureCEO]

Proud to see @AtriCure supporting and leading the @American_Heart Twin Cities Heart Ball - a force for community heart health! @elmouelhi @jnoznesky @p2simons @AnkitaBhalla24 @alink1983

[AtriCure, Inc. @AtriCure]

David received a few different treatments to try and restore NSR. Ultimately, he had Hybrid AF™ Therapy. Today, he says he’s back to his normal activities. Learn more about this novel treatment for LSPAF at #AHA2022 (booth 2604). @HeartNews
https://t.co/qco7tHQLZN

[Mike Carrel @AtriCureCEO]

Honored to host leaders from Century Medical (CMI) of #Japan at our #MasonOH headquarters today! Such excellent partners are critical to our success helping patients. #ThankYou @PappaPriv

[Mike Carrel @AtriCureCEO]

“Women with #Afib are undertreated, underdiagnosed and underrepresented.” All-star faculty exploring gender disparities in heart care during the Women’s Cardiac Health Awareness event online now.  @HelenmariG @Drroxmehran @AndreaRussoEP @TheHeartBeat3 @HughCalkinsMD